The recently FDA-approved Alcon AcrySof® ReSTOR®Apodized Diffractive
Posterior Chamber intraocular lens (IOL) is a landmark vision care technology providing good vision in patients for both distance and near without the need for reading glasses. Standard lens implants give good distance vision but often require the use of reading glasses for near vision.
Approved for use in patients by the FDA on March 23, 2005, the first lens implants were performed in Erie, Pennsylvania by Dr. Stamm in June 2005. Those patients are now excited that they are able to see to perform tasks at a distance such as driving without glasses, as well as near such as reading the newspaper, sewing, playing cards or looking at fine print without glasses. The FDA results of the ReSTOR® Multifocal were so good because the design of the lens is based on the highly-successful AcrySof lens implant that has been used in patients around the world for many years for standard cataract lens surgery. The ReSTOR® technology adds the Apodized Diffractive surface to this already successful lens to provide patients greater visual freedom. Only surgeons who have completed specialized training with Alcon Surgicial and have been approved by them will be authorized to perform these lens implants. Dr. Stamm completed his specialized training for this lens implant in Atlanta, Georgia in April 2005. Approval requires demonstrating that lens implant calculations are being made within a very close tolerance to assure the utmost accuracy and best implant results. |